The Motley Fool

Cineplex (TSX:CGX) Stock: DEVASTATED by the Pandemic

Image source: Getty Images

Cineplex (TSX:CGX) stock has been absolutely devastated by the COVID-19 pandemic. At its lowest point, it was down 87% for the year. As of this writing, it was still down 72%. In recent weeks, Cineplex saw a massive rally that helped pare the losses considerably. However the stock remains a  loser for those who bought at the beginning of the year. In this article, I’ll explore why that is the case and whether the company can recover.

COVID-19 destroyed movie theatres

Movie theatres were among the industries hardest hit by the COVID-19 pandemic. Like airlines and hotels, they saw their revenue tank when lockdowns were implemented. Unlike those industries, however, movie theatres weren’t able to carve out exemptions. For airlines, special categories like “essential travel” helped keep demand afloat at least somewhat. With movie theatres, there were no such exemptions. The result was an unbelievably rapid decline in revenue.

In the second quarter, Cineplex saw a 95% decline in revenue. That’s even worse than what Air Canada experienced. While Air Canada’s 88% revenue decline was bad, CGX at one point was earning no revenue. Early in the lockdowns, it was forced to close all of its theatres. The fact that the company earned any revenue at all in Q2 was merely due to the re-opening that began later in the quarter.

Vaccine uncertainties loom

Of course, all of the issues facing Cineplex today could be resolved overnight by the arrival of a COVID-19 vaccine. If a vaccine is released and quickly given to the majority of the population, then there’ll be no need for further lockdowns. In that scenario, Cineplex would be able to re-open almost all of its theatres overnight. Investors are aware of this, which is probably why CGX rallied more than 100% in the month following Pfizer’s vaccine announcement.

However, it would be a mistake for an investor to bet everything on the arrival of a COVID-19 vaccine. Vaccine deployment still has a number of question marks surrounding it, including:

  • Possible supply chain issues — like those Pfizer recently confessed to.
  • Issues getting the vaccine approved.
  • A new mutation of COVID-19 that the vaccine is not effective against.
  • People refusing to take the vaccine.
  • And many more.

Put simply, there’s no guarantee that a vaccine will magically make COVID-19 go away. If it doesn’t, then lockdowns remain a long-term possibility.

Foolish takeaway

Cineplex stock is down massively this year, but investors who bought in the last month have actually realized a great return. It would be a mistake, though, to take that one-month rally as indicative of future performance. All it would take is a big delay in vaccine deployment to blow CGX’s entire operation. So, the stock remains extremely risky.

If you like Cineplex, you'll like these stocks even more...

Just Released! 5 Stocks Under $49 (FREE REPORT)

Motley Fool Canada's market-beating team has just released a brand-new FREE report revealing 5 "dirt cheap" stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don't miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.

Claim your FREE 5-stock report now!

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss an important event.

Iain Butler and the Stock Advisor Canada team only publish their new “buy alerts” twice a month, and only to an exclusively small group.

This is your chance to get in early on what could prove to be very special investment advice.

Enter your email address below to get started now, and join the other thousands of Canadians who have already signed up for their chance to get the market-beating advice from Stock Advisor Canada.